Source BioScience Purchases Two Illumina GAIIx; Plans to Install HiSeq 2000 this Year

Jan 26, 2010

Premium

UK service provider Source BioScience has purchased two Illumina Genome Analyzer IIx systems and plans to bring the firm's HiSeq 2000 technology in house later this year, the company said this week.

Source BioScience said it has invested a total of £700,000 ($1.13 million) in the two systems and ancillary equipment, which will be housed in its Nottingham facility. It has had an Illumina GA since 2008.

In addition to the instrument purchase, Illumina has designated Source BioScience as a CSPro-certified service provider for its sequencing technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Featured White Papers

Automated Rare Disease Diagnostics

Sep

27

Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep

28

Featured Webinar

Clinical Utility of Comprehensive and Fast Genomic Interpretation

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.

Main menu